Neurolief
Neurolief is pioneering brain neuromodulation and digital therapeutics technology to treat depression and other neurological disorders.
Operating in health care, medical, medical device, mental health, neuroscience based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), Neurolief was founded in 2013.
The company sits in the health care, medical, medical device, mental health, neuroscience segment, where it competes on its core product or service.
The business is associated with Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
The company is listed at the Corporate_Round stage of development.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $20M.
| Sector | Health Care, Medical, Medical Device, Mental Health, Neuroscience |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2013 |
| Employees | c_00011_00050 |
| Stage | corporate_round |
| Total funding | $20,000,000 |
Website: www.neurolief.com
Browse related
Create a free account